---
schema_version: "secwatch.filing_event.v1"
accession: "0001021771-24-000033"
form_type: "8-K"
ticker: "BRTX"
cik: "0001505497"
company_name: "BioRestorative Therapies, Inc."
filed_at: "2024-02-08T23:59:59+00:00"
generated_at: "2026-06-06T05:36:07.927269+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# BioRestorative raises $8.1M via warrant exercise and new private placement warrants

## Summary
- Gross proceeds of $8.1M from exercise of existing warrants for 3,351,580 shares at $2.33/share.
- New warrants issued for up to 2,513,685 shares at $2.43/share, 5-year term, in a private placement.
- Proceeds to fund BRTX-100 clinical trials, metabolic ThermoStem R&D, and working capital.
- Roth Capital Partners served as financial advisor; fee approx. $528,000.
- Existing warrant shares already registered; resale registration for new warrants to be filed within 10 days.

## SEC filing metadata
- accession: 0001021771-24-000033
- form_type: 8-K
- ticker: BRTX
- cik: 0001505497
- company_name: BioRestorative Therapies, Inc.
- filed_at: 2024-02-08T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 1.01, 3.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1505497/000102177124000033/0001021771-24-000033-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1505497/000102177124000033/brt8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001021771-24-000033
- JSON: https://secwatch.observer/filing/0001021771-24-000033.json
- Plain text: https://secwatch.observer/filing/0001021771-24-000033.txt

## Key facts
- Material Agreements
  BioRestorative Therapies, Inc. entered into Agreements with certain holders of its existing warrants valued at approximately $8.1 million (effective 2024-02-06).
  - Action: entry
  - Agreement: atm program
  - Counterparty: certain holders of its existing warrants
  - Value: approximately $8.1 million
  - Effective: 2024-02-06
  source text: On February 6, 2024, BioRestorative Therapies, Inc. (the “Company”) entered into agreements (the “Agreements”) with certain holders of its existing warrants exercisable for an aggregate of 3,351,580 shares of its common stock (collectively, the “Existing Warrants”), to exercise their warrants at a reduced exercise price of $2.33 per share, in exchange for new warrants (the “New Warrants”) as described below.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1505497/000102177124000033/0001021771-24-000033-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.